OTHER BALANCE SHEET COMPONENTS (Tables)

6 Months Ended

Jun. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]


Table 9.1: Details of Other Assets
	June 30, 2026		December 31, 2025

	(in thousands)
Investment (1)	$	3,750	$	3,750
Prepaid expense and deferred commission – long-term portion	372		537
Restricted cash	141		140
Other	94		86
Other assets	$	4,357	$	4,513

(1) In March 2024, we made a $3.0 million investment in a privately-held company via a simple agreement for future equity ("SAFE"). In October 2025, the Company's SAFE investment was settled into 8,964,262 shares of Series A common stock at a settlement price of $0.42 per share, based on the valuation cap in the original agreement, resulting in 3.8% ownership with no significant influence over the privately-held company. Upon settlement of the SAFE, the investment was remeasured to its fair value of $3.8 million. The investment does not have a readily determinable fair value and the Company elected the measurement alternative to value its investment. The fair value of this investment was based on non-marketable observable inputs, which represent Level 3 measurement within the fair value hierarchy. The investment was carried at cost less impairment, if any, and subsequently measured to fair value upon observable price changes in an orderly transaction for the identical or similar investment of the same issuer, with any gains or losses recorded within "other income" on the unaudited consolidated statement of operations. We did not note any changes in the fair value during the three and six months ended June 30, 2026, and 2025.

Schedule of Other Current Liabilities


Table 9.2: Details of Accrued Liabilities
	June 30, 2026		December 31, 2025

	(in thousands)
Accrued project expenses	$	4,133	$	4,289
Restructuring expenses accrual	700		1,451
Other	840		1,160
Accrued liabilities	$	5,673	$	6,900